Antonio D’Alessio
Università degli Studi del Piemonte Orientale “Amedeo Avogadro”(IT)Hammersmith Hospital(GB)Portsmouth Hospitals NHS Trust(GB)King's College Hospital(GB)Imperial College London(GB)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Hepatocellular Carcinoma Treatment and Prognosis, Diabetes Treatment and Management, Renal cell carcinoma treatment, Pancreatic and Hepatic Oncology Research
Most-Cited Works
- → NASH limits anti-tumour surveillance in immunotherapy-treated HCC(2021)1,187 cited
- → Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child‐Pugh A and B cirrhosis: A real‐world study(2022)219 cited
- → ALBI grade: Evidence for an improved model for liver functional estimation in patients with hepatocellular carcinoma(2021)198 cited
- → T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma(2022)176 cited
- → Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis(2022)128 cited
- → One-Trocar Transumbilical Laparoscopic-Assisted Appendectomy in Children: Our Experience(2002)111 cited